Netherlands

In early July 2024, Dutch Organization for Health Research and Development (ZonMw) awarded seventeen projects under the Efficiency Research program, including four projects on e-health, two projects on diagnostic imaging techniques, two projects in orthopedics, one project on abdominal surgery, one project in gynecology, and one project in the cardiovascular area.

On July 10, 2024, the Dutch Organization for Health Research and Development (ZonMw) announced the submission of grant applications for research on patient-relevant outcomes and alternative forms of financing for innovative treatment under the Medical Specialist Care and Research (MedZO) program. The submission of grant applications will continue until October 15, 2024.

In August 2024, Dutch Organization for Health Research and Development (ZonMw) awarded four projects under the 2023 Round of the Care Evaluation and Appropriate Use program, including one project in orthopedics, one project on cardiovascular care, one project in cancer management and one project on urinary tract infection.

In the second quarter of 2024, the Dutch Healthcare Institute (ZIN) published four coverage positions on proton therapy in testicular cancer, pulmonary artery pressure remote monitoring in chronic heart failure and neuromodulation in polyneuropathy with positive recommendation for coverage under basic insurance package, and on physiotherapy and exercise therapy in primary care settings for lower back pain, which was not recommended for coverage under the basic insurance package.

On May 14, 2024, the Dutch Healthcare Authority (NZa) published another update of the 2024 Digital Care Funding Guide, which describes the possibilities for funding digital care depending on the healthcare sector, including new funding for Integrated Care Transformation Plans and the implementation of a novel platform for the assessment of innovative digital applications and/or technologies.

On May 07, 2024, the Dutch Healthcare Institute (ZIN) published the updated list of medical procedures reimbursed under basic health insurance with restrictions or limitations. The additional indications for autologous fat transplantation after a total breast removal were newly introduced to the list.

On May 01, 2024, the Dutch Healthcare Authority (NZa) published the first release of the 2025 DRG package (RZ25a). Three new procedure codes, five new supplementary payments, four new diagnosis codes and one new DRG will be implemented across gynecology, cardiology, neurology and neurosurgery, and other technology groups.

In April 2024, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two projects which received a subsidy under the "Subsidy scheme for promising care" in 2024 for research of targeted muscle reinnervation during leg amputation and thrombectomy by catheterization in adult patients with a high-risk pulmonary embolism.

In March 2024, the Dutch Organization for Health Research and Development (ZonMw) awarded subsidies under HTA Methodology Program for 2021-2024 for five projects intended for the development of a methodology for assessing technologies used in non-curative care.

In January 2024, the Dutch Healthcare Institute (ZIN) published an update of the “Guideline for conducting health economic evaluations”.

Dutch Healthcare Institute (ZIN) implemented the MedTech Horizon Scan to gain a better insight into the arrival of medical technological innovations).

On December 21, 2023, the Dutch Healthcare Authority (NZa) issued a draft release of the DRG package for 2025, including new procedure codes, new diagnosis codes, and several new DRGs. These changes concern gynecology, cardiology, gene therapy and other technology groups.